Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025
Dana-Farber Cancer Institute’s groundbreaking research continues to shape the landscape of oncology as their experts present a series of pivotal ...
Tag: Phase 3 clinical trials
Trastuzumab Emtansine Enhances Long-Term Survival Rates in HER2-Positive Breast Cancer Patients
In recent groundbreaking research, the significance of trastuzumab emtansine (T-DM1) has taken center stage in the battle against high-risk HER2-positive ...
POPULAR NEWS
-
Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission
-
Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps
-
ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy
-
New Study Suggests ALS and MS May Stem from Common Environmental Factor
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
